These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28076330)

  • 1. The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.
    Vriens IJ; De Bie AJ; Aarts MJ; de Boer M; van Hellemond IE; Roijen JH; van Golde RJ; Voogd AC; Tjan-Heijnen VC
    Oncotarget; 2017 Feb; 8(7):11372-11379. PubMed ID: 28076330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials.
    Furlanetto J; Marmé F; Seiler S; Thode C; Untch M; Schmatloch S; Schneeweiss A; Bassy M; Fasching PA; Strik D; Stickeler E; Schem C; Karn T; Grischke EM; Denkert C; van Mackelenbergh M; Müller V; Nekljudova V; Loibl S
    Eur J Cancer; 2021 Jul; 152():193-203. PubMed ID: 34116270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH
    World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.
    Malisic E; Susnjar S; Milovanovic J; Todorovic-Rakovic N; Kesic V
    Arch Gynecol Obstet; 2018 Feb; 297(2):495-503. PubMed ID: 29101609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of premature menopause induced by chemotherapy for early breast cancer.
    Lower EE; Blau R; Gazder P; Tummala R
    J Womens Health Gend Based Med; 1999 Sep; 8(7):949-54. PubMed ID: 10534297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer.
    Long JP; Wan F; Zhang F; Zhou J; Don LF
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1087-92. PubMed ID: 27049261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.
    Tabatabai LS; Bloom J; Stewart S; Sellmeyer DE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1257-62. PubMed ID: 26756114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
    van Hellemond IEG; Vriens IJH; Peer PGM; Swinkels ACP; Smorenburg CH; Seynaeve CM; van der Sangen MJC; Kroep JR; de Graaf H; Honkoop AH; Erdkamp FLG; van den Berkmortel FWPJ; Kitzen JJEM; de Boer M; de Roos WK; Linn SC; Imholz ALT; Tjan-Heijnen VCG;
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29546343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole.
    Krekow LK; Hellerstedt BA; Collea RP; Papish S; Diggikar SM; Resta R; Vukelja SJ; Holmes FA; Reddy PK; Asmar L; Wang Y; Fox PS; Peck SR; O'Shaughnessy J
    J Clin Oncol; 2016 May; 34(14):1594-600. PubMed ID: 26884554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
    Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
    Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy induced ovarian failure in breast cancer: Retrospective study of 100 cases].
    Amaadour L; El Mrabet FZ; Atreche L; El Rhazi K; Oualla K; Benbrahim Z; Arifi S; Mellas N
    Bull Cancer; 2020 Sep; 107(9):854-860. PubMed ID: 32762944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Kim HJ; Lee MH; Lee JE; Park S; Lee ES; Kang YJ; Shin HN; Kim SI; Lee JH; Im SA; Ahn SH; Lee KS; Sohn J; Kim S; Nam SJ; Han W
    Clin Breast Cancer; 2018 Oct; 18(5):e1165-e1172. PubMed ID: 29843988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function preservation with GnRH agonist in young breast cancer patients: does it impede the effect of adjuvant chemotherapy?
    Kim J; Kim M; Lee JH; Lee H; Lee SK; Bae SY; Jun SY; Kil WH; Lee JE; Kim SW; Nam SJ
    Breast; 2014 Oct; 23(5):670-5. PubMed ID: 25088482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
    McCune JS; Games DM; Espirito JL
    J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles.
    Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W
    PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
    BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.
    Yu B; Douglas N; Ferin MJ; Nakhuda GS; Crew K; Lobo RA; Hershman DL
    Cancer; 2010 May; 116(9):2099-105. PubMed ID: 20187091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.